Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  Betta Pharmaceuticals Co., Ltd.    300558   CNE100002DD9

BETTA PHARMACEUTICALS CO., LTD.

(300558)
  Report
End-of-day quote. End-of-day quote SHENZHEN STOCK EXCHANGE - 12/03
97.17 CNY   +5.19%
 SummaryChartsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
11/27/2020 11/30/2020 12/01/2020 12/02/2020 12/03/2020 Date
90.7 91.29 92.29 92.38 97.17 Last
3528085 3409118 3802176 3298917 7583152 Volume
-1.07% +0.65% +1.10% +0.10% +5.19% Change
Financials
Sales 2020 1 954 M 299 M 299 M
Net income 2020 470 M 71,9 M 71,9 M
Net Debt 2020 849 M 130 M 130 M
P/E ratio 2020 96,4x
Yield 2020 0,27%
Sales 2021 2 693 M 412 M 412 M
Net income 2021 467 M 71,4 M 71,4 M
Net Debt 2021 1 059 M 162 M 162 M
P/E ratio 2021 87,5x
Yield 2021 0,32%
Capitalization 39 162 M 5 986 M 5 992 M
EV / Sales 2020 20,5x
EV / Sales 2021 14,9x
Nbr of Employees 1 328
Free-Float 100%
More Financials
Company
Betta Pharmaceuticals Co., Ltd. is a China-based company principally engaged in the research and development, manufacturing, sales and marketing of drugs to treat malignant tumors, diabetes, cardiovascular and cerebrovascular diseases. The Company’s core product is icotinib, which is a kind of antineoplastic agent. Its products also include burn pain relieving plaster, oryzanol vitamin B1 and vitamin B6 tablets.... 
Sector
Pharmaceuticals
Calendar
04/28Earnings Release
More about the company
Notations Surperformance© of Betta Pharmaceuticals Co., Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about BETTA PHARMACEUTICALS CO., LTD.

- No features available -

More news
News in other languages on BETTA PHARMACEUTICALS CO., LTD.

- No features available -

More news
Chart BETTA PHARMACEUTICALS CO., LTD.
Duration : Period :
Betta Pharmaceuticals Co., Ltd. Technical Analysis Chart | 300558 | CNE100002DD9 | MarketScreener
Technical analysis trends BETTA PHARMACEUTICALS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Average target price 80,22 CNY
Last Close Price 97,17 CNY
Spread / Highest target -10,5%
Spread / Average Target -17,4%
Spread / Lowest Target -24,4%
EPS Revisions
Managers
NameTitle
Lie Ming Ding Chairman, Co-Chief Executive Officer & GM
Jia Tong Co-Chief Executive Officer & Secretary
Yang Nan Zhang Chairman-Supervisory Board
Jian Xun Fan Chief Financial Officer & Vice President
Jia Bing Wang Director, Senior Vice President & Chief Scientist
Sector and Competitors
1st jan.Capitalization (M$)
BETTA PHARMACEUTICALS CO., LTD.47.90%5 986
MERCK KGAA28.33%71 018
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD103.99%20 446
KYOWA KIRIN CO., LTD.11.39%14 808
YUHAN CORPORATION38.48%3 515
RECIPHARM AB (PUBL)32.26%2 057